Substrates for peptidase S01.161: kallikrein-related peptidase 2
Peptide and protein substrates that are thought to be physiologically relevant are indicated by P. Peptide and protein substrates that are thought to be pathologically relevant are indicated by D. Peptide and protein substrates that are not physiologically relevant are indicated by N. Synthetic substrates are indicated by S. Click on the symbol to show only physiological, non-physiological or synthetic substrates, or here to display all substrates. How cleavage sites have been identified are indicated by the following evidence codes: NT = N-terminal sequencing, MS = mass spectroscopy, MU = mutation, CS = consensus sequence, LC = liquid chromatography. To see all annotated cleavages for a protein substrate, click on the UniProt Accession.
| Substrate | Uniprot | Residue range | Cleavage Site | Cleavage type | Evidence | P4 | P3 | P2 | P1 | P1' | P2' | P3' | P4' | Reference | CutDB | MERNUM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ala-Arg-Arg-NHMec | Ala-Arg-Arg+NHMec | S | - | Ala | Arg | Arg | AMC | - | - | - | Lovgren et al., 1999 | |||||
| alpha-1-antichymotrypsin | P01011 | 24-423 | peptide-Leu383+Ser-peptide | P | Ile | Thr | Leu | Leu | Ser | Ala | Leu | Val | Mikolajczyk et al., 1999 | 3382 | ||
| D-Pro-Phe-Arg-NHPhNO2 | D-Pro-Phe-Arg+NHPhNO2 | S | - | DPr | Phe | Arg | NAN | - | - | - | Mikolajczyk et al., 1998 | |||||
| fibronectin | P02751 | 32-2386 | peptide-Arg290+Ala-peptide | P | Thr | Asp | Val | Arg | Ala | Ala | Val | Tyr | Deperthes et al., 1996 | 20423 | ||
| fibronectin | P02751 | 32-2386 | peptide-Arg2059+Thr-peptide | P | Gly | Phe | Arg | Arg | Thr | Thr | Pro | Pro | Deperthes et al., 1996 | 20413 | ||
| gurmarin | P25810 | 1-35 | peptide-Tyr13+Tyr-peptide | P | Cys | Ile | Pro | Tyr | Tyr | Leu | Asp | Cys | Yamada et al., 2006 | 20217 | ||
| insulin-like growth factor-binding protein 2 | P18065 | 40-328 | peptide-Arg200+Gln-peptide | P | MS | Glu | Gln | His | Arg | Gln | Met | Gly | Lys | Rehault et al., 2001 | 20390 | |
| Kallikrein-1 precursor | P06870 | 19-262 | peptide-Arg24+Ile-peptide | P | NT | Ile | Gln | Ser | Arg | Ile | Val | Gly | Gly | Yoon et al., 2007 | 17295 | |
| Kallikrein-11 precursor | Q9UBX7 | 51-282 | Glu-Thr-Arg53+Ile-peptide | P | NT | - | Glu | Thr | Arg | Ile | Ile | Lys | Gly | Yoon et al., 2007 | ||
| Kallikrein-12 precursor | Q9UKR0 | 18-248 | Ala-Thr-Pro-Lys21+Ile-peptide | P | NT | Ala | Thr | Pro | Lys | Ile | Phe | Asn | Gly | Yoon et al., 2007 | ||
| Kallikrein-13 precursor | Q9UKR3 | 17-277 | peptide-Lys25+Val-peptide | P | NT | Glu | Ser | Ser | Lys | Val | Leu | Asn | Thr | Yoon et al., 2007 | ||
| Kallikrein-5 precursor | Q9Y337 | 23-293 | peptide-Arg66+Ile-peptide | P | NT | Ser | Ser | Ser | Arg | Ile | Ile | Asn | Gly | Yoon et al., 2007 | ||
| Kallikrein-6 precursor | Q92876 | 17-244 | peptide-Lys21+Leu-peptide | P | NT | Glu | Gln | Asn | Lys | Leu | Val | His | Gly | Yoon et al., 2007 | ||
| Kallikrein-9 precursor | Q9UKQ9 | 16-250 | peptide-Arg22+Ala-peptide | P | NT | Ala | Asp | Thr | Arg | Ala | Ile | Gly | Ala | Yoon et al., 2007 | ||
| kallikrein-related peptidase 11 isoform 2 | Q9UBX7 | 51-282 | peptide-Arg188+Leu-peptide | P | Pro | Gln | Leu | Arg | Leu | Pro | His | Thr | Luo et al., 2006 | 20973 | ||
| kallikrein-related peptidase 2 | P20151 | 19-261 | Pro-Leu-Ile-Gln-Ser-Arg+Ile-peptide | P | Ile | Gln | Ser | Arg | Ile | Val | Gly | Gly | Mikolajczyk et al., 1998 | 21002 | ||
| kallikrein-related peptidase 2, prostatic isoform 1 | P20151 | 1-261 | peptide-Arg169+Ser-peptide | P | Leu | Arg | Pro | Arg | Ser | Leu | Gln | Cys | Väisänen et al., 2002 | 20232 | ||
| kallikrein-related peptidase 2, prostatic isoform 1 | P20151 | 234-260 | peptide-Arg250+Lys-peptide | N | Val | His | Tyr | Arg | Lys | Trp | Ile | Lys | Mikolajczyk et al., 1998 | 21003 | ||
| kallikrein-related peptidase 3 | P07288 | 17-261 | peptide-Arg24+Ile-peptide | P | Ile | Leu | Ser | Arg | Ile | Val | Gly | Gly | Takayama et al., 1997 | 20239 | ||
| kininogen-1 | P01042 | 19-644 | peptide-Lys362+Arg-peptide | P | Ser | Leu | Met | Lys | Arg | Pro | Pro | Gly | 17293 | |||
| kininogen-1 | P01042 | 19-644 | peptide-Arg371+Ser-peptide | P | Ser | Pro | Phe | Arg | Ser | Ser | Arg | Ile | 17294 | |||
| kininogen-1 | P01042 | 19-644 | peptide-Arg427+Arg-peptide | P | Gly | His | Thr | Arg | Arg | His | Asp | Trp | Charlesworth et al., 1999 | 21064 | ||
| kininogen-1 | P01042 | 19-644 | peptide-Arg437+Lys-peptide | P | Glu | Lys | Gln | Arg | Lys | His | Asn | Leu | Charlesworth et al., 1999 | 21065 | ||
| kininogen-1 | P01042 | 19-644 | peptide-Arg457+Gly-peptide | P | Gly | His | Gln | Arg | Gly | His | Gly | Leu | Charlesworth et al., 1999 | 21066 | ||
| phage display clone 5.10 | Ile-Gly-Gly-Gly-Ile-Met-Ser-Arg+Gln-Gly-Ser-Thr-Gly-Gly-Gly-Ser-His-His-His-His-His-His | S | Ile | Met | Ser | Arg | Gln | Gly | Ser | Thr | Cloutier et al., 2002 | |||||
| phage display clone 5.14 | Ile-Gly-Gly-Gly-Arg+Asn-Asp-Lys-Leu-Gly-Ser-Thr-Gly-Gly-Gly-Ser-His-His-His-His-His-His | S | Gly | Gly | Gly | Arg | Asn | Asp | Lys | Leu | Cloutier et al., 2002 | |||||
| phage display clone 5.18 | Ile-Gly-Gly-Gly-Glu-Arg+Val-Ser-Pro-Gly-Ser-Thr-Gly-Gly-Gly-Ser-His-His-His-His-His-His | S | Gly | Gly | Glu | Arg | Val | Ser | Pro | Gly | Cloutier et al., 2002 | |||||
| phage display clone 5.19 | Ile-Gly-Gly-Gly-Thr-Leu-Gln-Arg+Val-Gly-Ser-Thr-Gly-Gly-Gly-Ser-His-His-His-His-His-His | S | Thr | Leu | Gln | Arg | Val | Gly | Ser | Thr | Cloutier et al., 2002 | |||||
| phage display clone 5.3 | Ile-Gly-Gly-Gly-Thr-Arg+Ala-Pro-Met-Gly-Ser-Thr-Gly-Gly-Gly-Ser-His-His-His-His-His-His | S | Gly | Gly | Thr | Arg | Ala | Pro | Met | Gly | Cloutier et al., 2002 | |||||
| phage display clone 5.4 | Ile-Gly-Gly-Gly-Thr-Gly-Ser-Arg+Asp-Gly-Ser-Thr-Gly-Gly-Gly-Ser-His-His-His-His-His-His | S | Thr | Gly | Ser | Arg | Asp | Gly | Ser | Thr | Cloutier et al., 2002 | |||||
| phage display clone 5.5 | Ile-Gly-Gly-Gly-Glu-Thr-Lys-Arg+Ser-Gly-Ser-Thr-Gly-Gly-Gly-Ser-His-His-His-His-His-His | S | Glu | Thr | Lys | Arg | Ser | Gly | Ser | Thr | Cloutier et al., 2002 | |||||
| phage display clone 5.7 | Ile-Gly-Gly-Gly-Ser-Gly-Arg+Leu-Ala-Gly-Ser-Thr-Gly-Gly-Gly-Ser-His-His-His-His-His-His | S | Gly | Ser | Gly | Arg | Leu | Ala | Gly | Ser | Cloutier et al., 2002 | |||||
| phage display clone 6.1 | Ile-Gly-Gly-Gly-Met-Thr-Arg+Ser-Asn-Gly-Ser-Thr-Gly-Gly-Gly-Ser-His-His-His-His-His-His | S | Gly | Met | Thr | Arg | Ser | Asn | Gly | Ser | Cloutier et al., 2002 | |||||
| phage display clone 6.12 | Ile-Gly-Gly-Gly-Gly-Thr-Leu-Arg+Phe-Gly-Ser-Thr-Gly-Gly-Gly-Ser-His-His-His-His-His-His | S | Gly | Thr | Leu | Arg | Phe | Gly | Ser | Thr | Cloutier et al., 2002 | |||||
| phage display clone 6.14 | Ile-Gly-Gly-Gly-Arg-Gly-Arg+Met-Ala-Gly-Ser-Thr-Gly-Gly-Gly-Ser-His-His-His-His-His-His | S | Gly | Arg | Gly | Arg | Met | Ala | Gly | Ser | Cloutier et al., 2002 | |||||
| phage display clone 6.15 | Ile-Gly-Gly-Gly-Val-Arg+Pro-Leu-Glu-Gly-Ser-Thr-Gly-Gly-Gly-Ser-His-His-His-His-His-His | S | Gly | Gly | Val | Arg | Pro | Leu | Glu | Gly | Cloutier et al., 2002 | |||||
| phage display clone 6.19 | Ile-Gly-Gly-Gly-Gly-Val-Phe-Arg+Ser-Gly-Ser-Thr-Gly-Gly-Gly-Ser-His-His-His-His-His-His | S | Gly | Val | Phe | Arg | Ser | Gly | Ser | Thr | Cloutier et al., 2002 | |||||
| phage display clone 6.2 | Ile-Gly-Gly-Gly-Arg-Arg+Ser-Ile-Asp-Gly-Ser-Thr-Gly-Gly-Gly-Ser-His-His-His-His-His-His | S | Gly | Gly | Arg | Arg | Ser | Ile | Asp | Gly | Cloutier et al., 2002 | |||||
| phage display clone 6.20 | Ile-Gly-Gly-Gly-Ala-Arg+Ala-Ser-Glu-Gly-Ser-Thr-Gly-Gly-Gly-Ser-His-His-His-His-His-His | S | Gly | Gly | Ala | Arg | Ala | Ser | Glu | Gly | Cloutier et al., 2002 | |||||
| phage display clone 6.3 | Ile-Gly-Gly-Gly-Leu-Thr-Thr-Ser-Lys+Gly-Ser-Thr-Gly-Gly-Gly-Ser-His-His-His-His-His-His | S | Thr | Thr | Ser | Lys | Gly | Ser | Thr | Gly | Cloutier et al., 2002 | |||||
| phage display clone 6.4 | Ile-Gly-Gly-Gly-Pro-Ser-Ala-Arg+Met-Gly-Ser-Thr-Gly-Gly-Gly-Ser-His-His-His-His-His-His | S | Pro | Ser | Ala | Arg | Met | Gly | Ser | Thr | Cloutier et al., 2002 | |||||
| phage display clone 6.5 | Ile-Gly-Gly-Gly-Thr-Val-Arg+Met-Pro-Gly-Ser-Thr-Gly-Gly-Gly-Ser-His-His-His-His-His-His | S | Gly | Thr | Val | Arg | Met | Pro | Gly | Ser | Cloutier et al., 2002 | |||||
| phage display clone 6.6 | Ile-Gly-Gly-Gly-Lys-Thr-Arg+Ser-Asn-Gly-Ser-Thr-Gly-Gly-Gly-Ser-His-His-His-His-His-His | S | Gly | Lys | Thr | Arg | Ser | Asn | Gly | Ser | Cloutier et al., 2002 | |||||
| phage display clone 6.7 | Ile-Gly-Gly-Gly-Lys-Leu-Arg+Thr-Thr-Gly-Ser-Thr-Gly-Gly-Gly-Ser-His-His-His-His-His-His | S | Gly | Lys | Leu | Arg | Thr | Thr | Gly | Ser | Cloutier et al., 2002 | |||||
| phage display clone 8.11 | Ile-Gly-Gly-Gly-Val-Leu-Arg+Ser-Pro-Gly-Ser-Thr-Gly-Gly-Gly-Ser-His-His-His-His-His-His | S | Gly | Val | Leu | Arg | Ser | Pro | Gly | Ser | Cloutier et al., 2002 | |||||
| phage display clone 8.12 | Ile-Gly-Gly-Gly-Leu-Arg+Met-Pro-Thr-Gly-Ser-Thr-Gly-Gly-Gly-Ser-His-His-His-His-His-His | S | Gly | Gly | Leu | Arg | Met | Pro | Thr | Gly | Cloutier et al., 2002 | |||||
| phage display clone 8.17 | Ile-Gly-Gly-Gly-Pro-Gly-Arg+Ala-Pro-Gly-Ser-Thr-Gly-Gly-Gly-Ser-His-His-His-His-His-His | S | Gly | Pro | Gly | Arg | Ala | Pro | Gly | Ser | Cloutier et al., 2002 | |||||
| phage display clone 8.19 | Ile-Gly-Gly-Gly-Thr-Arg-Asp-Ser-Arg-Gly-Ser-Thr-Gly-Gly-Gly-Ser-His-His-His-His-His-His | S | Gly | Gly | Thr | Arg | Asp | Ser | Arg | Gly | Cloutier et al., 2002 | |||||
| phage display clone 8.20 | Ile-Gly-Gly-Gly-Leu-Arg+Ser-Arg-Ala-Gly-Ser-Thr-Gly-Gly-Gly-Ser-His-His-His-His-His-His | S | Gly | Gly | Leu | Arg | Ser | Arg | Ala | Gly | Cloutier et al., 2002 | |||||
| phage display clone 8.3 | Ile-Gly-Gly-Gly-Arg-Gly-Arg+Ser-Glu-Gly-Ser-Thr-Gly-Gly-Gly-Ser-His-His-His-His-His-His | S | Gly | Arg | Gly | Arg | Ser | Glu | Gly | Ser | Cloutier et al., 2002 | |||||
| phage display clone 8.9 | Ile-Gly-Gly-Gly-Ala-Arg-Ala-Arg+Ser-Gly-Ser-Thr-Gly-Gly-Gly-Ser-His-His-His-His-His-His | S | Ala | Arg | Ala | Arg | Ser | Gly | Ser | Thr | Cloutier et al., 2002 | |||||
| phage display clone PCI | Ile-Gly-Gly-Gly-Thr-Phe-Arg+Ser-Ala-Gly-Ser-Thr-Gly-Gly-Gly-Ser-His-His-His-His-His-His | S | Gly | Thr | Phe | Arg | Ser | Ala | Gly | Ser | Cloutier et al., 2002 | |||||
| plasma serine protease inhibitor | P05154 | 20-406 | peptide-Arg373+Ser-peptide | P | Phe | Thr | Phe | Arg | Ser | Ala | Arg | Leu | Mikolajczyk et al., 1999 | 3381 | ||
| plasminogen activator inhibitor-1 | P05121 | 24-402 | peptide-Arg369+Met-peptide | P | Val | Ser | Ala | Arg | Met | Ala | Pro | Glu | Mikolajczyk et al., 1999 | |||
| Pro-Phe-Arg-NHMec | Pro-Phe-Arg+NHMec | S | - | Pro | Phe | Arg | AMC | - | - | - | Lovgren et al., 1999 | |||||
| semenogelin-1 | P04279 | 24-462 | peptide-Arg137+Gly-peptide | P | Lys | Ala | His | Arg | Gly | Thr | Gln | Asn | Lovgren et al., 1999 | 20650 | ||
| semenogelin-1 | P04279 | 24-462 | peptide-Arg297+Leu-peptide | P | Glu | Glu | Arg | Arg | Leu | His | Tyr | Gly | Lovgren et al., 1999 | 20652 | ||
| semenogelin-1 | P04279 | 24-462 | peptide-Arg372+Ser-peptide | P | Val | Ser | Gln | Arg | Ser | Ile | Tyr | Ser | Lovgren et al., 1999 | 20653 | ||
| semenogelin-2 | Q02383 | 24-582 | peptide-His124+Met-peptide | P | Gly | His | Phe | His | Met | Ile | Val | Ile | Lovgren et al., 1999 | 3384 | ||
| semenogelin-2 | Q02383 | 24-582 | peptide-Arg165+Leu-peptide | P | Thr | Glu | Lys | Arg | Leu | Trp | Val | His | Lovgren et al., 1999 | 3385 | ||
| semenogelin-2 | Q02383 | 24-582 | peptide-Arg245+Leu-peptide | P | His | Gln | Asp | Arg | Leu | Gln | His | Gly | Lovgren et al., 1999 | 3386 | ||
| semenogelin-2 | Q02383 | 24-582 | peptide-Arg292+Thr-peptide | P | Pro | Ser | Ser | Arg | Thr | Glu | Glu | Arg | Lovgren et al., 1999 | 3387 | ||
| semenogelin-2 | Q02383 | 24-582 | peptide-Arg391+Ile-peptide | P | Asn | Gln | Val | Arg | Ile | Pro | Ser | Gln | Lovgren et al., 1999 | 3388 | ||
| semenogelin-2 | Q02383 | 24-582 | peptide-Arg477+Leu-peptide | P | Glu | Glu | Arg | Arg | Leu | Asn | Tyr | Gly | Lovgren et al., 1999 | 3389 | ||
| semenogelin-2 | Q02383 | 24-582 | peptide-Arg545+Tyr-peptide | P | Gln | Lys | Gly | Arg | Tyr | Lys | Gln | Glu | Lovgren et al., 1999 | 3390 | ||
| urokinase-type plasminogen activator | P00749 | 21-431 | peptide-Lys158+Ile-peptide | P | Pro | Arg | Phe | Lys | Ile | Ile | Gly | Gly | 17296 |
